TerminatedNCT01676766

Novel Quantification Methods for Fluorescence to Detect Progression in Stargardt Disease

Studying Stargardt disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Michigan
Principal Investigator
K. Thiran Jayasundera, MD
University of Michigan Kellogg Eye Center
Enrollment
2 target
Eligibility
5-18 years · All sexes
Timeline
2012 – 2016

Study locations (1)

Collaborators

Midwest Eye Banks

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01676766 on ClinicalTrials.gov

Other trials for Stargardt disease

Additional recruiting or active studies for the same condition.

See all trials for Stargardt disease →

← Back to all trials